Comparison of the Lipid-Lowering Effects of Pitavastatin 4 mg Versus Pravastatin 40 mg in Adults With Primary Hyperlipidemia or Mixed (Combined) Dyslipidemia: A Phase IV, Prospective, US, Multicenter, Randomized, Double-blind, Superiority Trial
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference23 articles.
1. Lipid-lowering therapy: who can benefit?;Lewis;Vasc Health Risk Manag,2011
2. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines [Published correction appears in Circulation. 2004;110:763];Grundy;Circulation,2004
3. Prevalence of uncontrolled risk factors for cardiovascular disease: United States, 1999–2010. NCHS data brief, no 103;Fryar,2012
4. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report;Circulation,2002
5. Managing abnormal blood lipids: a collaborative approach;Fletcher;Circulation,2005
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. A Systematic Review of Randomized Clinical Trials on the Efficacy and Safety of Pitavastatin;Current Reviews in Clinical and Experimental Pharmacology;2023-07
2. A comprehensive review on the lipid and pleiotropic effects of pitavastatin;Progress in Lipid Research;2021-11
3. Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses;BMJ;2021-07-14
4. Preventive Effect of Pretreatment with Pitavastatin on Contrast-Induced Nephropathy in Patients with Renal Dysfunction Undergoing Coronary Procedure: PRINCIPLE-II Randomized Clinical Trial;Journal of Clinical Medicine;2020-11-17
5. Evaluation of the Pharmacokinetic Drug–Drug Interaction between Micronized Fenofibrate and Pitavastatin in Healthy Volunteers;Pharmaceutics;2020-09-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3